NO20051146L - Fremgangsmate for fremstilling av mellomprodukter nyttige for fremstilling av tubulininhibitorer - Google Patents

Fremgangsmate for fremstilling av mellomprodukter nyttige for fremstilling av tubulininhibitorer

Info

Publication number
NO20051146L
NO20051146L NO20051146A NO20051146A NO20051146L NO 20051146 L NO20051146 L NO 20051146L NO 20051146 A NO20051146 A NO 20051146A NO 20051146 A NO20051146 A NO 20051146A NO 20051146 L NO20051146 L NO 20051146L
Authority
NO
Norway
Prior art keywords
preparation
intermediates useful
tubulin inhibitors
useful
tubulin
Prior art date
Application number
NO20051146A
Other languages
English (en)
Inventor
Thurairajah Padmanathan
Panolil Raveendranath
Sreenivasulu Megati
Constantine Gletsos
John Thomas Kendall
Bogdan Kazimierz Wilk
Yanzhong Wu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20051146L publication Critical patent/NO20051146L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/16—Preparation of optical isomers
    • C07C231/18—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/02—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from isocyanates with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/08—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/06—Sulfinamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)

Abstract

Foreliggende oppfinnelse vedrører en fremgangsmåte for fremstilling og forbindelser med formel (l): som er mellomprodukter nyttige for fremstilling av tubulininhibitorer som er nyttige ved behandling av cancer.
NO20051146A 2002-09-20 2005-03-03 Fremgangsmate for fremstilling av mellomprodukter nyttige for fremstilling av tubulininhibitorer NO20051146L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41202402P 2002-09-20 2002-09-20
PCT/US2003/028661 WO2004026814A2 (en) 2002-09-20 2003-09-12 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors

Publications (1)

Publication Number Publication Date
NO20051146L true NO20051146L (no) 2005-04-18

Family

ID=32030783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051146A NO20051146L (no) 2002-09-20 2005-03-03 Fremgangsmate for fremstilling av mellomprodukter nyttige for fremstilling av tubulininhibitorer

Country Status (16)

Country Link
US (2) US6951955B2 (no)
EP (1) EP1539682A2 (no)
JP (1) JP2006500407A (no)
KR (1) KR20050054951A (no)
CN (1) CN1705639A (no)
AR (1) AR041321A1 (no)
AU (1) AU2003299042A1 (no)
BR (1) BR0314128A (no)
CA (1) CA2498759A1 (no)
EC (1) ECSP055693A (no)
MX (1) MXPA05002874A (no)
NO (1) NO20051146L (no)
RU (1) RU2005111753A (no)
TW (1) TW200409745A (no)
WO (1) WO2004026814A2 (no)
ZA (1) ZA200502275B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297896B2 (en) * 2002-11-21 2007-11-20 Hadco Santa Clara, Inc. Laser trimming of resistors
EP1567302B8 (en) * 2002-11-21 2013-05-15 Hadco Santa Clara, Inc. Laser trimming of resistors
ITRM20050345A1 (it) * 2005-06-30 2007-01-01 Sigma Tau Ind Farmaceuti Sintesi di deossi-biotinil esametilen diammina-dota.
CN102485726B (zh) * 2010-12-02 2015-07-01 天津药明康德新药开发有限公司 一种1-r-1’-螺-(哌啶-4,4’-喹啉)-2’(3’-氢)酮的制备方法
MX368258B (es) 2013-03-15 2019-09-25 Zymeworks Inc Compuestos citotoxicos y antimitoticos y metodos de uso de los mismos.
CN106459162A (zh) 2013-12-27 2017-02-22 酵活有限公司 Var2csa‑药物偶联物
KR102384740B1 (ko) 2013-12-27 2022-04-07 자임워크스 인코포레이티드 약물 접합체를 위한 설폰아마이드-함유 연결 시스템
HUE057768T2 (hu) 2014-09-17 2022-06-28 Zymeworks Inc Citotoxikus és antimitotikus vegyületek és azok alkalmazásának módszerei
US10517958B2 (en) 2016-10-04 2019-12-31 Zymeworks Inc. Compositions and methods for the treatment of platinum-drug resistant cancer
TWI758313B (zh) * 2016-10-12 2022-03-21 美商陶氏農業科學公司 一種用於製備(1r,3r)-及(1s,3s)-2,2-二鹵基-3-(經取代之苯基)環丙烷甲酸的方法
CN109580801B (zh) * 2018-06-26 2021-09-07 深圳海王医药科技研究院有限公司 一种检测微管蛋白抑制剂及相关杂质的高效液相色谱法
CN110343056B (zh) * 2019-07-19 2022-01-07 爱斯特（成都）生物制药股份有限公司 一种n-叔丁氧羰基-n-甲基-2-氨基-4,4-二甲基戊酸的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9508195D0 (en) * 1995-04-20 1995-06-07 Univ British Columbia Novel biologically active compounds and compositions,their use and derivation
CA2225325A1 (en) * 1997-12-19 1999-06-19 The University Of British Columbia Hemiasterlin analogs
JP2884081B1 (ja) * 1998-02-13 1999-04-19 名古屋大学長 アリールホウ素化合物触媒を用いたアルデヒド類又はケトン類の製造方法
EP1531846A4 (en) * 2002-02-27 2006-04-19 Us Gov Health & Human Serv CONJUGATES OF LIGAND, LINK AND CYTOTOXIC AGENS, AND RELATED COMPOSITIONS AND USE PROCESSES

Also Published As

Publication number Publication date
TW200409745A (en) 2004-06-16
EP1539682A2 (en) 2005-06-15
ECSP055693A (es) 2005-05-30
MXPA05002874A (es) 2005-05-27
CA2498759A1 (en) 2004-04-01
WO2004026814A2 (en) 2004-04-01
US20040063904A1 (en) 2004-04-01
ZA200502275B (en) 2007-10-31
US7078572B2 (en) 2006-07-18
CN1705639A (zh) 2005-12-07
RU2005111753A (ru) 2005-11-20
US6951955B2 (en) 2005-10-04
AU2003299042A1 (en) 2004-04-08
JP2006500407A (ja) 2006-01-05
US20050288486A1 (en) 2005-12-29
AR041321A1 (es) 2005-05-11
BR0314128A (pt) 2005-06-28
WO2004026814A3 (en) 2004-08-12
KR20050054951A (ko) 2005-06-10

Similar Documents

Publication Publication Date Title
NO20051146L (no) Fremgangsmate for fremstilling av mellomprodukter nyttige for fremstilling av tubulininhibitorer
AP1699A (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
NO20070933L (no) Indazoler anvendbare i behandling av kardiovaskulaere sykdommer
NO20091864L (no) Forbindelser for inhibering av mitotisk progresjon
NO20062561L (no) Kinoliner nyttige for behandling av kardiovaskulaere sykdommer
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
IL178675A0 (en) Monocyclic heterocycles as kinase inhibitors
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
NO20052796L (no) Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese
NO20092412L (no) Hydantoinderivater anvendes som MMP-inhibitorer
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
NO20082496L (no) Pyrazinderivater
EP1794120A4 (en) peptidase
NO20073571L (no) Nye hydantoinderivater som metallproteinaseinhibitorer
NO20091626L (no) MGLUR5-modulatorer
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
UA85087C2 (en) Monocyclic heterocycles as kinase inhibitors
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
TW200745106A (en) Chemical compounds
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
NO20071805L (no) Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere.
NO20076000L (no) Aminosyrederivater